SCHEMBL8224935

SCHEMBL8224935

COc1nc2ccccc2nc1/C=C/c1cccnc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.53
CYP11B2 P19099 1/20 0.53
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
GRM5 P41594 1/20 0.43
ALOX5 P09917 1/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
CYP1A1 P04798 3/20 0.43
CYP1A2 P05177 3/20 0.43
CYP1B1 Q16678 3/20 0.43
CYP2D6 P10635 2/20 0.42
CYP3A4 P08684 1/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42
CHRNA7 P36544 1/20 0.42
CHRNA4 P43681 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8219137 0.86 KDM4E (0.48) NPC1RAB9AMEN1KMT2APTGS2
SCHEMBL13594777 0.85 CYP11B1 (0.49) CYP11B1CYP11B2NPC1RAB9AMEN1
SCHEMBL13595004 0.85 CYP11B1 (0.49) CYP11B1CYP11B2NPC1RAB9AMEN1
SCHEMBL12669909 0.85 CYP11B1 (0.49) CYP11B1CYP11B2NPC1RAB9AMEN1
SCHEMBL8226827 0.79 TRPA1 (0.56) NPC1RAB9AALOX5PTGS2CYP1A1
SCHEMBL7936491 0.76 MEN1 (0.41) NPC1RAB9AMEN1KMT2ACYP1A2
SCHEMBL15958645 0.75 MAPT (0.52) NPC1RAB9AMEN1KMT2APTGS1
SCHEMBL8212824 0.75 ALOX5 (0.38) NPC1RAB9AMEN1KMT2AALOX5
SCHEMBL9000529 0.75 CYP11B1 (0.69) CYP11B1CYP11B2NPC1RAB9AMEN1
SCHEMBL9000534 0.75 CYP11B1 (0.69) CYP11B1CYP11B2NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809264-B2 Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2014-08-19 US disclosed
US-7635683-B2 Quinoxalinyl tripeptide hepatitis C virus inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2009-12-22 US disclosed
WO-2008002924-A2 QUINOXALINYL MACROCYCLIC HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2008-01-03 WO disclosed